Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin

Yaakov Nahmias1, Jonathan Goldwasser, Monica Casali

  • 1Center for Engineering in Medicine, Shriners Burns Hospital, Boston, MA, USA. ynahmias@partners.org

Insights

The grapefruit flavonoid naringenin significantly reduces Hepatitis C virus (HCV) secretion by inhibiting very low density lipoprotein (vLDL) assembly and release. This offers a promising new therapeutic strategy for treating chronic liver disease caused by HCV infection.

Area of Science:

  • Hepatology
  • Virology
  • Biochemistry

Background:

  • Hepatitis C virus (HCV) is a major global cause of chronic liver disease.
  • HCV interacts with host lipid metabolism and lipoproteins for its lifecycle.
  • The mechanism of HCV secretion involves association with very low density lipoprotein (vLDL).

Purpose of the Study:

  • To investigate the role of very low density lipoprotein (vLDL) in Hepatitis C virus (HCV) secretion.
  • To evaluate the potential of naringenin, a grapefruit flavonoid, as an antiviral agent against HCV.

Main Methods:

  • Investigated HCV secretion via a Golgi-dependent mechanism linked to vLDL.
  • Utilized apolipoprotein B (ApoB) messenger RNA silencing to assess its impact on HCV secretion.
  • Examined the effect of naringenin on vLDL secretion, microsomal triglyceride transfer protein (MTP) activity, and key lipid-related gene transcription in HCV-infected cells.

Main Results:

  • Silencing ApoB reduced secretion of both ApoB-100 and HCV by 70%.
  • Naringenin inhibited MTP activity and the transcription of HMGCR and ACAT2.
  • Naringenin treatment decreased HCV secretion by 80% at non-toxic concentrations in hepatocytes and mice.

Conclusions:

  • HCV is secreted via a vLDL-dependent pathway.
  • Naringenin effectively inhibits HCV secretion by targeting lipid metabolism pathways.
  • Naringenin represents a potential novel therapeutic for Hepatitis C virus infection.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...